MARSHBANKS TRACY 4
4 · ANI PHARMACEUTICALS INC · Filed Apr 19, 2018
Insider Transaction Report
Form 4
MARSHBANKS TRACY
Director
Transactions
- Sale
Common Stock
2018-04-18$62.09/sh−33,200$2,061,388→ 450,601 total(indirect: See Footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).